SkinHealth Systems Inc. (SKIN)

From the record

SkinHealth Systems Inc.'s filings since 2020 show 7 warning events of 4 kinds: a notice about its exchange listing (8-K item 3.01, 2 times, the latest 2026-05-12); a warning not to rely on past financial statements (8-K item 4.02, the latest 2021-05-10); an auditor change (8-K item 4.01, the latest 2021-07-12); a late-report notice (Form NT 10-K or NT 10-Q, 3 times, the latest 2024-02-29) (its current reports).

From the record

SkinHealth Systems Inc.'s 7 filed years say what it did: revenue went from $167 million in fiscal 2019 to $301 million in fiscal 2025, up 10.3% a year; it rose in 3 of 6 years; the deepest fall was 29% from fiscal 2019 to fiscal 2020; net income was positive in 1 of 7 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, SkinHealth Systems Inc.'s diluted share count shrank about 2.9% a year, and dividends and buybacks returned about 40% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 0 sales and 0 purchases of their own stock on the open market in the year to 2026-10-13 (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, SkinHealth Systems Inc. lost about 16 cents for every dollar of shareholders' money, and gross profitability: its products earned about 39 cents per dollar of everything the company owns. Leverage: it owed about 88 cents per dollar of assets, and net share issuance: its share count shrank 4.7% over the year (the filed statements).

From the record

SkinHealth Systems Inc.'s standing among 109 graded names in its industry family: revenue of $301 million in fiscal 2025 ranks in the top 34% by size; a net margin of -3.2% ranks in the top 34%; revenue growth of -6.3% a year over the last 3 filed years ranks in the bottom 17% (its annual reports).

From the record

SkinHealth Systems Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Malha, Pedro Bruno Ferreira (President and CEO, as filed), filing under that title since 2025-10-10, 1.1 years (bottom 22% of its family); the 8 officers and directors filing in the last fifteen months have been on the record a median of 1.1 years (bottom 2%); 19 officer or director changes were reported on Form 8-K since 2023-11-13, against the 8 people in charge now (bottom 2%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

SkinHealth Systems Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $233 million against no long-term debt tagged leaves 46.6% of its assets as net cash, top 19% of its family; cash from operations less capital spending is 12.4% of revenue (top 21%); a gross margin of 65.3% (top 39%); research spending of 1.9% of revenue (bottom 8%) (its annual report).

From the record

SkinHealth Systems Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew -6.3% a year over the last three filed years against 10.3% over all 7, slowing (bottom 21% of its family); the newest year grew -10% (bottom 14%); research spending grew -12.6% a year (bottom 12%); capital spending grew -69.6% a year (bottom 6%) (its annual reports). SkinHealth Systems Inc. reported 2 product lines in fiscal 2025: Consumables at $213 million (71%), Delivery Systems at $88 million (29%); 1 of 2 grew against the year before (its annual report).

From the record

SkinHealth Systems Inc.'s newest year against its own record: revenue of $301 million in fiscal 2025 came in 5.9% below the $320 million its prior three years' pace pointed to (bottom 41% of its family); net income of $10 million against a prior three-year average of $28 million (top 28%); a net margin of -3.2% against -7.3% before (bottom 38%) (its annual reports).